Welcome To Our Genvio Group

  • Sep 14-15, 2020

  • Venice

  • Italy

  • World Congress on

    Diabetes and endocrinology

    Sep 14-15, 2020 | Venice | Italy
    Theme : Recent Strategies and Innovations in Diabetes & Endocrinology

    About the Conference


    Genvio Conferences invites you to join us at the “World Congress on Diabetes and endocrinology”-WCDE 2020 where you will be assured to have a meaningful experience with scholars from around the world. The organizing committee looks forward to meeting you  all at Venice, Italy at September 14-15,  2020.

    The Conference relies on the theme of: “To Translate and harness novel therapies in Diabetes and Endocrinology.” Meet the Global Inspiring experts and speakers at our  World Congress on Diabetes and endocrinology which will focus in bringing together individuals who have an interest in different fields of Endocrinology, Diabetes and Metabolic Disorders such as Endocrinologists, Diabetologists, Ophthalmologist, Medical Professors, Researchers, Diabetes and Endocrinology Scientists, Practitioners, Physical trainer or Exercise physiologist, Medical students.

    This conference is a unique platform for researchers and clinicians to present analysis regarding endocrine and diabetic disease management and complications, exchanging ideas about it and thus contributes to the dissemination of knowledge in the society.

    The two days conference will include workshops, symposiums, special keynote sessions conducted by eminent speakers within the sector of medical science related to diabetes and endocrine complications.

    The Diabetes Congress 2020 highlights the theme “To Translate and harness novel therapies in Diabetes and Endocrinology” emphasize on the latest advancements in prevention and treatment of various metabolic diseases which may be due to diabetic and endocrine complications and provides robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Diabetes & Endocrine Complications.

    • Exchanging of ideas and networking with renowned leading Diabetologists, endocrinologists, polygenic disease researchers, clinician’s researchers, nurses,  polygenic disease and medical professionals and researchers from across the world.

    •  Medical doctors, health care providers consider the prevention of Diabetes diseases as an essential tool to improve the general health status of the population.

    •  Learn and discuss about diabetes complications and challenges with our Keynote speakers.

    •    With seminars, panel discussions, roundtable conference discussions, and workshops, we tend to cover each and every topic from top to bottom, from global macro issues to tactical issues.

     

    Global diabetes market is expected to grow at a CAGR of 7.6% percent for the forecasted period of 2018-2023. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 8.9%. Some of the top selling diabetic drugs include Lantus (Sanofi), Januvia (Merck And Co), Humalog (Eli Lily And Co), Novorapid (Novo Nordisk), Levemir (Novo Nordisk), Victoza (Novo Nordisk), Janumet (Merck And Co.), Novolog (Novo Nordisk), Humalin (Eli Lily And Co.) And Galvus (Novartis). With the diabetic population expected to cross the 350 million market by 2030 the market is expected to show strong growth rate. Diabetic drugs are highly priced which could be one of the major drawbacks.

    Endocrinology is the part of solution managing endocrine and metabolic issue. The endocrine system is made of hormone-producing glands, such as the thyroid, parathyroid, pancreas, ovaries, testes, adrenals, pituitary, and hypothalamus. These hormones control reproduction, metabolism, and growth and development. Most endocrine issues are unending and require ceaseless treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid, and hyper parathyroid disorders, and osteoporosis Some less regular however genuine endocrine issue incorporates, yet are not constrained to Addison's illness, Cushing's disorder, pheochromocytoma, and clusters of sexual advances.

    In the United States, the most well-known endocrine illness is diabetes mellitus. Diabetes mellitus is a gathering of sicknesses arranged by a lack of insulin creation or the capacity of the body to utilize it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes have made endocrinology/ metabolic one of the most in-demand and important medical sects.

    All abstracts must be written exclusively in English (including the title, abstract text, author names and affiliations).
    Modes of Presentation:

    • Oral presentation
    • Poster presentation

      Visa Information

    • Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.
    • Genvio conferences will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.
    • Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of including the inability to obtain a visa.

    Scientific Sessions


    • Diabetes and vascular diseases
    • Diabetes and Nutrition
    • Biomarkers of Diabetes Mellitus
    • Pediatric diabetes
    • Endocrine Disorders
    • Diabetes mellitus type 2
    • Diabetes mellitus type 1
    • Pediatric diabetes
    • Complications associated with Diabetes
    • Diabetic Cardiomyopathy
    • Diabetic Nephropathy
    • Diabetic Retinopathy
    • Diabetic Foot and ankle
    • Gestational diabetes Mellitus
    • Advanced Technologies for the Treatment of Diabetes
    • Endocrinology and Metabolism
    • Endocrinology and Diabetes
    • Adrenal and Thyroid Disorders
    • Neuroendocrinology and Pituitary Disorders
    • Diabetes risk management
    • Clinical Endocrinology
    • Pediatric Endocrinology
    • Endocrinology Glands and Hormones
    • Diabetic Retinopathy
    • Diabetes: Oral complications
    • Diabetics and Pancreas
    • Diabetes and Gastroparesis
    • Current Trends & Advancements in Diabetes Research
    • Diabetes Care and prevention
    • Neuroendocrinology
    • Diagnosis of Diabetes
    • Alternative therapies
    • Global Diabetes Market
    • Diabetes and Periodontitis
    • Diabetes and HHNS
    • Diabetes and DKA
    • Hyperglycemia and Hypoglycemia
    • Islet Transplantation
    • Metabolic Changes in Diabetes
    • Diabetic Coma and Nursing
    • Obesity and Metabolism
    • Diabetes mellitus and obesity
    • Endocrinology Glands and Hormones
    • Diabetic Encephalopathy
    • Obesity Surgery

    Committee


    Masahiro Onuma
    President of Trisguide Ltd, Japan
    Edson da Silva
    Federal University, Brazil
    Osama A Tolba El Razaky
    Tanta University, Egypt
    Ulrike Rothe
    Dresden University, Germany
    Karsten Buschard
    Bartholin Institute, Denmark
    Serge Bottari
    University Grenoble Alpes, France
    Mahmoud El-Borai
    Alexandria Unversity, Egypt
    Maria Diakonova
    University of Toledo, USA
    Hayat Mushcab
    Johns Hopkins Aramco Healthcare, Saudi Arabia
    Yasser Mostafa Hafez
    Tanta University, Egypt
    Ling He
    Johns Hopkins University, USA
    Nanduri Jayasri
    The University of Chicago, USA
    Mustafa Z. Younis
    Jackson State University, USA
    Dana Al-Hamwi
    Emirates Diabetes Society, UAE
    Dario Furnari
    University of Exeter , UK
    Pietro Muretto
    Hospital of Pesaro, Italy
    Lacombe Veronique
    Oklahoma State University, USA
    Khalil Amal I
    King Saud bin Abdul-Aziz University for health sciences, Jeddah
    Patricia Taylor
    Case Western Reserve University, USA
    Ibrahim El Bayoumy
    Tanta University, Egypt
    Media Partners and collaborations

    Speakers

    Eduardo Antonio Donadi
    University of São Paulo, Brazil
    Geetendra Singh Dhanawat
    Aditya Bharti Centre For Diabetes, India
    Pramod Kumar
    King Fahad Hospital, Saudi Arabia
    Mohamed Saad Hamed Mahmoud
    Ain Shams University, Egypt
    Hayat Mushcab
    Johns Hopkins Aramco Healthcare, Saudi Arabia
    Luis Sobrevia
    University of Queensland, Australia
    Mona S Zaki
    National Research Centre, Egypt
    Jaideep khare
    Peoples Medical College, India
    Pasquale Cancelliere
    Massachusetts Foot and Ankle Specialists, USA
    Chumpon Wilasrusmee
    Mahidol University, Thailand
    Bilkis Banu
    Heidelberg university, Germany
    Rp Agrawal
    Diabetes Care & Research Centre, India
    Nanduri Jayasri
    The University of Chicago, USA
    Maher Kamel
    Alexandria University, Egypt
    Nakhoul Farid
    Bar-Ilan University, Israel

    Conference Starts in


    • Days

    • Hours

    • Mins

    • Secs

    Contact Us


    © Copyright 2019 Genvio All rights reserved.